Remote Digital Technologies for the Early Detection and Monitoring of Cognitive Decline in Patients With Type 2 Diabetes: Insights From Studies of Neurodegenerative Diseases

被引：0
|
作者：
DuBord, Ashley Y. [1 ,2 ]
Paolillo, Emily W. [1 ]
Staffaroni, Adam M. [1 ]
机构：
[1] Univ Calif San Francisco, Weill Inst Neurosciences, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA
[2] 2 Diabet Technol Soc, Burlingame, CA USA
来源：
JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY | 2024年 / 18卷 / 06期
关键词：
type; 2; diabetes; Alzheimer's disease; mild cognitive impairment; cognitive decline; digital biomarkers; health technology; ALZHEIMERS-DISEASE; AUTOMATIC DETECTION; OLDER-ADULTS; IMPAIRMENT; DEMENTIA; MELLITUS; BATTERY; INSULIN; RECOGNITION; PERFORMANCE;
D O I：
10.1177/19322968231171399
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Type 2 diabetes (T2D) is a risk factor for cognitive decline. In neurodegenerative disease research, remote digital cognitive assessments and unobtrusive sensors are gaining traction for their potential to improve early detection and monitoring of cognitive impairment. Given the high prevalence of cognitive impairments in T2D, these digital tools are highly relevant. Further research incorporating remote digital biomarkers of cognition, behavior, and motor functioning may enable comprehensive characterizations of patients with T2D and may ultimately improve clinical care and equitable access to research participation. The aim of this commentary article is to review the feasibility, validity, and limitations of using remote digital cognitive tests and unobtrusive detection methods to identify and monitor cognitive decline in neurodegenerative conditions and apply these insights to patients with T2D.
引用
收藏
页码：1489 / 1499
页数：11
相关论文
共 50 条
  • [41] Polyvascular disease and increased risk of cardiovascular events in patients with type 2 diabetes: Insights from the EXSCEL trial
    Samsky, Marc D.
    Mentz, Robert J.
    Stebbins, Amanda
    Lokhnygina, Yuliya
    Aday, Aaron W.
    Pagidipati, Neha J.
    Jones, W. Schuyler
    Katona, Brian G.
    Patel, Manesh R.
    Holman, Rury R.
    Hernandez, Adrian F.
    Gutierrez, Jorge Antonio
    ATHEROSCLEROSIS, 2021, 338 : 1 - 6
  • [42] Microvascular Determinants of Cognitive Decline and Brain Volume Change in Elderly Patients with Type 2 Diabetes
    de Bresser, Jeroen
    Reijmer, Yael D.
    van den Berg, Esther
    Breedijk, Marja A.
    Kappelle, L. Jaap
    Viergever, Max A.
    Biessels, Geert Jan
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2010, 30 (05) : 381 - 386
  • [43] Type 2 Diabetes Mellitus May Exacerbate Gray Matter Atrophy in Patients With Early-Onset Mild Cognitive Impairment
    Li, Chang
    Zuo, Zhiwei
    Liu, Daihong
    Jiang, Rui
    Li, Yang
    Li, Haitao
    Yin, Xuntao
    Lai, Yuqi
    Wang, Jian
    Xiong, Kunlin
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [44] Prescribing pattern of statins for primary prevention of cardiovascular diseases in patients with type 2 diabetes: insights from Ethiopia
    Demoz, Gebre Teklemariam
    Wahdey, Shishay
    Kasahun, Gebremicheal Gebreslassie
    Hagazy, Kalay
    Kinfe, Daniel Gebrehawaria
    Tasew, Hagos
    Bahrey, Degena
    Niriayo, Yirga Legesse
    BMC RESEARCH NOTES, 2019, 12 (1)
  • [45] Pathological Between-Network Positive Connectivity in Early Type 2 Diabetes Patients Without Cerebral Small Vessel Diseases
    Liu, Huanghui
    Liu, Jun
    Liu, Huasheng
    Peng, Limin
    Feng, Zhichao
    Hong, Pengfei
    Shen, Hui
    Hu, Dewen
    Zeng, Ling-Li
    Wang, Wei
    FRONTIERS IN NEUROSCIENCE, 2019, 13
  • [46] Magnetic Resonance Imaging-Visible Perivascular Spaces in the Basal Ganglia Are Associated With the Diabetic Retinopathy Stage and Cognitive Decline in Patients With Type 2 Diabetes
    Choi, Eun Young
    Park, Yae Won
    Lee, Minyoung
    Kim, Min
    Lee, Christopher Seungkyu
    Ahn, Sung Soo
    Kim, Jinna
    Lee, Seung-Koo
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
  • [47] Glycemic control and self-monitoring of blood glucose in Chinese patients with type 2 diabetes on insulin: Baseline results from the COMPASS study
    Ji, L.
    Su, Q.
    Feng, B.
    Shan, Z.
    Hu, R.
    Xing, X.
    Xue, Y.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 112 : 82 - 87
  • [48] Insights Into Patients' Experience With Type 1 Diabetes: Exit Interviews From Phase III Studies of Sotagliflozin
    Ervin, Claire
    Joish, Vijay N.
    Evans, Emily
    DiBenedetti, Dana
    Reaney, Matthew
    Preblick, Ronald
    Castro, Rita
    Danne, Thomas
    Buse, John B.
    Lapuerta, Pablo
    CLINICAL THERAPEUTICS, 2019, 41 (11) : 2219 - 2230
  • [49] Brain imaging correlates of mild cognitive impairment and early dementia in patients with type 2 diabetes mellitus
    Groeneveld, O.
    Reijmer, Y.
    Heinen, R.
    Kuijf, H.
    Koekkoek, R.
    Janssen, J.
    Rutten, G.
    Kappelle, L.
    Biessels, G.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2018, 28 (12) : 1253 - 1260
  • [50] Original Type 2 diabetes mellitus predicts cognitive decline: Evidence from the Irish longitudinal study on ageing (TILDA)
    Cominetti, Marcia Regina
    Pott-Junior, Henrique
    Cominetti, Cristiane
    Zunigab, Raquel Gutierrez
    Romero-Ortuno, Roman
    DIABETES EPIDEMIOLOGY AND MANAGEMENT, 2022, 7
12345